PRINTER'S NO. 2774
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE RESOLUTION
No.
661
Session of
2015
INTRODUCED BY FREEMAN, HENNESSEY, DONATUCCI, KIM, KIRKLAND,
COHEN, BAKER, SONNEY, DUSH, TOOHIL, LONGIETTI, DRISCOLL,
DiGIROLAMO, BIZZARRO, HARHART, KILLION, BOYLE, ROZZI,
D. COSTA, NEILSON, ROEBUCK, PICKETT, BOBACK, SCHLOSSBERG,
MILLARD, V. BROWN, MURT, WARD, READSHAW, MACKENZIE, THOMAS,
WHEELAND, WATSON, PAYNE, GROVE, ROSS, FARINA, MAHONEY, MAJOR,
MARSICO, KAVULICH, DeLUCA, GILLEN AND GINGRICH,
JANUARY 28, 2016
INTRODUCED AS NONCONTROVERSIAL RESOLUTION UNDER RULE 35,
JANUARY 28, 2016
A RESOLUTION
Designating the month of March 2016 as "Fibromuscular Dysplasia
Awareness Month" in Pennsylvania.
WHEREAS, Fibromuscular Dysplasia (FMD) is a disease that
causes abnormal cell growth of the arterial wall and can lead to
areas of narrowing, beading, aneurysms and tearing of the
arterial wall; and
WHEREAS, FMD patients present the same symptoms that affect
much of the general population, including hypertension,
headaches and dizziness; and
WHEREAS, There has been little progress in understanding the
disease since it was first diagnosed in 1938; and
WHEREAS, There is no known cause or cure for the disease, and
there are no set protocols for its treatment; and
WHEREAS, FMD is classified as a rare disease, though many
1
2
3
4
5
6
7
8
9
10
11
12
13
14
researchers believe it is underdiagnosed; and
WHEREAS, Women comprise 90% of patients diagnosed with FMD;
and
WHEREAS, Individuals and families affected by FMD often
experience isolation, difficulty in obtaining accurate and
timely diagnosis and less than optimal treatment options, and
often they must educate their own physicians about the disease;
and
WHEREAS, The Fibromuscular Dysplasia Society of America
(FMDSA) was founded in March 2003 and over the past 13 years has
been active and successful in raising public and physician
awareness of the disease, increasing patient support and working
with researchers around the world; and
WHEREAS, FMDSA is also funding the United States Registry of
Fibromuscular Dysplasia; and
WHEREAS, FMDSA is organizing a global observance of FMD to
have patients, medical professionals and researchers join
together to focus attention on FMD as a public health issue;
therefore be it
RESOLVED, That the House of Representatives designate the
month of March 2016 as "Fibromuscular Dysplasia Awareness Month"
in Pennsylvania.
20160HR0661PN2774 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22